Interestingly, FEZF1 was shown to upregulate the expression of the oncogenic gene CDC25A, activating the PI3K/AKT pathway and promoting the malignant behavior of glioma stem cells [44]. The gene discussed is AKT1; the disease is central nervous system cancer.